Delivery Order 75N95023D00009-75N95023F00001

Award Date 3/14/23
Potential Completion Date 3/13/28
Potential Value $2.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Brunswick, NJ 08901, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Rutgers, The State University of New Jersey was awarded a $2.5 million firm fixed-price delivery order against the National Institutes of Health National Institute on Drug Abuse's Center for Genetic Studies indefinite delivery/indefinite quantity contract. Under the one-year task order, Rutgers will provide research services in support of NIDA's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health....
Rutgers, The State University has been awarded a firm fixed price delivery order against the National Institute on Drug Abuse Indefinite Delivery Contract to provide genetic research services. The $26,238.10 contract from the Department of the Navy Bureau of Medicine and Surgery will support Rutgers' continued operation of the NIDA Center for Genetic Studies through December 2023. As the prime contractor, Rutgers will receive, process, store, and distribute de-identified clinical data and...
The National Institute on Drug Abuse (NIDA) Center for Genetic Studies awarded a $2.5 million firm fixed price delivery order contract to Rutgers, The State University Research Financial Services Division for the period of March 14, 2022 through March 13, 2023. As the prime contractor, Rutgers, The State University Research Financial Services Division will provide research services in support of NIDA's Center for Genetic Studies, with performance taking place in New Brunswick, New Jersey.
This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University to establish and operate the NIDA Center for Genetic Studies. The contract is a single-award Indefinite Delivery Contract valued at $2,144,869.96 to support the continued genetic research services for the Center between September 2019 and September 2022, with a potential extension through March 2028. The contract is not designated as a set-aside. As the...
This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The $2,499,626.17 contract is for the NIDA Center for Genetic Studies, providing services such as receiving, processing, storing, and distributing de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023...
This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract is for the NIDA Center for Genetic Studies, with a period of performance from March 14, 2020 to March 13, 2021 and a ceiling value of $2,499,999.99. The contract was awarded as a Firm Fixed Price task order under a larger Indefinite Delivery Contract (IDC) that Rutgers holds with NIDA, which has...
This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...
This is a $79,442.40 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Rutgers, The State University. The contract is for the creation of induced pluripotent stem cells, which are a type of stem cell that can be derived from adult cells. The contract does not have a set-aside designation. Rutgers, a major public research institution, has a long history of receiving federal...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a firm-fixed-price purchase order contract to Rutgers, The State University in the amount of $16,820.23. The contract, which has a completion date of June 30, 2025, is for the provision of custom mouse model CRISPR gene editing services. Rutgers, a major public research institution and 1862 land grant university, will leverage its expertise...
  • 75N95023D00009
    Indefinite Delivery Contract
  • 75N95023D00009-75N95023F00001
    Delivery Order

Rutgers, The State University has been awarded a task order against an existing National Institute on Drug Abuse (NIDA) indefinite delivery contract to establish and operate the NIDA Center for Genetic Studies. The task order, valued at $2,716,366, provides continued genetic research services for the Center between March 2023 and March 2024. Specifically, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over the five-year period of the underlying contract. The Center furthers NIDA's mission by facilitating genetic research on substance use disorders. The task order was awarded on a firm-fixed price basis by the Department of Health and Human Services National Institutes of Health NIDA. No set-aside designation was applied.

Generated 2/20/24, 3:10 PM